InvestorsHub Logo

oneragman

07/24/21 2:59 PM

#347931 RE: rafunrafun #347930

raf, the memory is definitely not as sharp as it once was, but wasn't death reduced by 20% in RI?( going from memory) I hope you are right, but believe because of the 20%, the statistical significance was there, but not even close to the numbers for MI and stroke. We no doubt got screwed, but am so use to it by now...and in the end, does it even matter? I sometimes think management keeps banging their heads against a wall and somehow think they are going to get different results...the next time.

ggwpq

07/24/21 4:33 PM

#347942 RE: rafunrafun #347930

NVS is positioning to push their upcoming PCSK9 drug once they gain FDA approval,

https://www.fiercepharma.com/pharma/novartis-sets-date-for-inclisiran-crl-response-but-what-about-fda-approval-timeline